Download Adoption of recent amendments to joint food standards under the Australia New Zealand Food Standards Code Notice, Amendments. 231, 234, 240, 247, 250, and 252

Australian Amendments No. 231, 234, 240, 247, 250 and 252. These amendments are set out below:

Resulting from P1028, Amendment No. 231 amends standards 1.1.2, 1.2.3, 1.3.1, 1.5.1, 2.9.2, 2.9.3, 2.9.5, and schedules 8, 15, 19, 25, and 29 to:
• Update the definitions relating to infant formula products.
• Align compositional requirements with the latest scientific evidence and recently updated international regulations. This includes updating:
o the calculation of energy, protein and vitamin A content of infant formula products,
o the provisions for composition relating to fatty acids, vitamins and minerals, and other substances to infant formula products,
o the optional nutritive substances which infant formula products may contain (i.e. not mandatory),
o to clarify the novel food permissions in relation to infant formula products, and
o the food additive, and contaminant provisions.
• Update the required format for a nutrition information statement for infant formula products.

This notice does not adopt amendments in Amendment No. 231 to Australian only standard 2.9.1.

Resulting from A1260, Amendment 234 amends schedules 3 and 18 to:
• Permit 2-methyloxolane as an extraction solvent processing aid.

Amendment 234 contains A1289 and A1291. Amendments from these applications were adopted on 15 May 2025.

Resulting from A1307 and 1308, Amendment 240 amends schedules 3, 26 and 29 to:
• Permit the use of milk fat globule membrane enriched whey protein concentrate as a nutritive substance in infant formula products.
• Permit a new genetically modified source organism Escherichia coli W for the production of 2′-Fucosyllactose (2′-FL) in infant formula products.

Amendment 240 contains A1279, A1310 and A1311. Amendments from these applications were adopted on 31 July 2026.

Resulting from A1324, Amendment 247 amends schedules 3, 26 and 29 to:
• Permit the voluntary addition of 3-fucosyllactose, a human-identical milk oligosaccharide, in infant formula products.

Amendment 247 contains A1333. Amendments from this application were adopted on 23 March 2026.

Resulting from A1334, Amendment 250 amends schedules 3 and 26 to:
• Permit the voluntary addition of a new genetically modified source of 2′-fucosyllactose in infant formula products.

Amendment 250 contains P1056. Amendments from this proposal were adopted on 19 August 2026.

Resulting from A1329, A1339 and A1340, Amendment 252 amends schedules 3, 19, 26 and 29 to:
• Exempt Blacklip Rock Oysters (Saccostrea spathulata) farmed in the Northern Territory from the cadmium (Cd) maximum level (ML) of 2 mg/kg for molluscs.
• Permit the voluntary use of 2′-FL, 3-FL, LNT, 3′-SL, and 6′-SL, alone or in combination, as nutritive substances in infant formula products.
• Permit GM Escherichia coli BL21 (gene donor: Akkermansia muciniphila) for the production of 2′-FL for use as a nutritive substance in infant formula products.